Coleman Blaise

Avg. Two Year Performance

(72%) Avg. Purchase Return

(31%) Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	9%	(15%)	(21%)	103%	(72%)
Purchase Success Rate	1 of 1	0 of 1	0 of 1	1 of 1	0 of 1
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Endo International plc

Drugs » Drug Manufacturers - Other

President, CEO, Director:

Holdings: 1.76M shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--